Search clinical trials for: MT-3724

Total 258 results

Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects

Healthy

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers

Healthy

Netherlands
Mitsubishi Tanabe Pharma Corporation

Completed

Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy

Diabetic Nephropathy

Japan
Universidade Federal do Rio de Janeiro
Maternidade Escola da UFRJ; Instituto de Puericultura e Pediatria Martagão...

Completed

Effects of Music Therapy on Breastfeeding Among Mothers of Premature Newborns

Breastfeeding

Brazil
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR

Diabetic Nephropathy

Romania, Bulgaria, Hungary, Poland, Czech Republic, Slovakia
Myeloid Therapeutics

Recruiting

Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors (MYE Symphony)

Epithelial Tumors, Malignant

Australia
Marker Therapeutics, Inc.

Active, not recruiting

Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant (ARTEMIS)

Acute Myeloid Leukemia | Stem Cell Transplantation

United States
Mitsubishi Tanabe Pharma America Inc.

Active, not recruiting

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

EPP | XLP

United States, Germany, Japan, Spain, Italy, Sweden, Australia, Canada, Norway, United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Mass Balance Study With MT-7117 (MT-7117 MB)

Healthy Volunteer

United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Mass Balance Study With MT-8554 (MT-8554 MB)

Healthy Volunteer

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects

Healthy

United Kingdom
5 Santé
Institut National de la Santé Et de la Recherche Médicale, France; Centre Hospitalier...

Completed

Effects of Training in Healthy Sedentary Subjects

Sedentary Subjects

France
Chang Gung Memorial Hospital

Unknown

Augmenting the Effects of Mirror Therapy for Stroke Rehabilitation by tDCS

Cerebrovascular Accident

Taiwan
Medicago
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）

SARS-CoV-2 Infection

Japan
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord Injury

Spinal Cord Injury

United States
University of Miami

Completed

Mindfulness Training for Seniors

Well Aging

United States
Myeloid Therapeutics

Suspended

A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL (IMAGINE)

Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Lymphoma, T-Cell, Peripheral | Cell Therapy | Adoptive Cellular Immunotherapy

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors (MANTLE)

Fibrosis | Dysphagia | Cancer Survivor | Head and Neck Carcinoma

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

Tardive Dyskinesia

Japan
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety and Efficacy Study of MT-2990 in Women With Endometriosis

Endometrial Related Pain

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

Healthy Subjects

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Renal Impairment | Normal Renal Function

Germany
Senju Pharmaceutical Co., Ltd.
PPD

Terminated

A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration

Age-related Macular Degeneration

United States
Mitsubishi Tanabe Pharma Corporation

Completed

A Clinical Study to Investigate How Safe and Tolerable the Study Drug MT-2990 is and How MT-2990 is Taken up by the Body in Healthy Volunteers

Healthy

Netherlands
Mitsubishi Tanabe Pharma Corporation

Completed

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

Crohn's Disease

France, Israel, Italy, Netherlands, Poland, Slovakia, Ukraine, Czech Republic, Germany, Hungary, Japan
Chang Gung Memorial Hospital

Recruiting

Novel Brain Neurotechnology for Optimizing Precision Mirror Therapy in Stroke

Cerebrovascular Accident

Taiwan
Zhuhai Yufan Biotechnologies Co., Ltd

Recruiting

A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor | Advanced Solid Malignancies

China
Zhuhai Yufan Biotechnologies Co., Ltd

Recruiting

A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor | Advanced Solid Malignancies

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Diffuse Cutaneous Systemic Sclerosis

Spain, Belgium, United States, United Kingdom, Poland, Canada, Germany, Italy
Gerencia Atencion Primaria Area 3
University of Alcala

Completed

Manual Therapy Effectiveness in Comparison With Electric Nerve Stimulation (TENS) in Patients With Neck Pain

Neck Pain

Spain
Komagome Hospital
Japan Agency for Medical Research and Development; Prism Pharma Co., Ltd.

Completed

A Follow-up Evaluation Study of PRI-724-1101

Hepatitis C Virus-infected Cirrhosis

Japan
Toray Industries, Inc

Terminated

Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis

Uremic Pruritus

United States
Moscow Scientific and Practical Center of Medical...

Recruiting

Substantiation and Standardization of the Multimodal Cognitive-motor Rehabilitation System for Afterstroke Patients

Stroke Rehabilitation

Russian Federation
Munich Municipal Hospital

Recruiting

Impact of a Standardized Alarming System on Treatment Times and Workflow in Stroke Patients With Interhospital Transfer for Thrombectomy

Acute Ischemic Stroke

Germany
Mitsubishi Tanabe Pharma Corporation

Recruiting

A Study of MT-0551 in Patients With Systemic Sclerosis

Systemic Sclerosis

Japan
Anaconda Biomed S.L.

Completed

ANAIS Study to Confirm the Safety and Performance of the ANA 5F Advanced Neurovascular Access® (ANAIS)

Acute Ischemic Stroke

Spain
Mitsubishi Tanabe Pharma Corporation

Completed

Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy

Painful Diabetic Peripheral Neuropathy

Japan
Chang Gung Memorial Hospital

Completed

Efficacy and Time Dependent Effects of tDCS Combined With MT for Rehabilitation After Subacute and Chronic Stroke

Cerebrovascular Accident

Taiwan
Stragen France

Completed

First-In-Human PainCart Study for STR-324

Pain

Netherlands
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan

Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease

Japan
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI); Remastered Sleep LLC

Recruiting

Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study

Snoring | Obstructive Sleep Apnea

United States
Exact Sciences Corporation

Completed

An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now

Colorectal Cancer

United States
Banc de Sang i Teixits
European Regional Development Fund; Ministerio de Sanidad, Servicios Sociales... and other collaborators

Completed

Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head

Avascular Necrosis of Femur Head

Spain
The Miriam Hospital
National Center for Complementary and Integrative Health (NCCIH)

Completed

Health Improvement Project - Providence (HIP)

HIV

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI); BerGenBio ASA

Terminated

AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery

Brain and Central Nervous System Tumors

United States
Brown University
University of Pittsburgh Medical Center; Richard King Mellon Foundation

Completed

A Mindfulness Approach to UA for Afro-descendants

Stress | Anxiety

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan

Anemia; Hemodialysis Dependent Chronic Kidney Disease

Japan
Molecular Templates, Inc.

Terminated

Study of MT-5111 in HER2-positive Solid Tumors (MT-5111)

HER2-positive Solid Cancers

United States, Australia, New Zealand
Brown University
National Institute on Aging (NIA)

Completed

Targeting Worry to Improve Sleep

Anxiety | Sleep Disturbance

United States
University of Chile
Comisión Nacional de Investigación Científica y Tecnológica

Unknown

Physical Activity Enhancement Using Pedometers in COPD

COPD

Chile

Search clinical trials for: MT-3724

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations